Envisioning treating genetically-defined urinary tract malformations with viral vector-mediated gene therapy

Area of Science:

• Urology
• Genetics
• Developmental Biology

Background:

• Human urinary tract malformations (UTMs) lead to severe health issues like kidney failure and are often diagnosed prenatally.
• Current treatments for UTMs do not address the underlying genetic causes.
• Advances in understanding monogenic causes of UTMs provide new therapeutic targets.

Purpose of the Study:

• To explore the potential of viral vector-mediated gene therapy for treating human urinary tract malformations.
• To leverage genetic insights into UTMs for novel therapeutic strategies.
• To propose a research pathway for developing gene therapies for UTMs.

Main Methods:

• Reviewing established gene therapy techniques used for other monogenic diseases.
• Examining the expression patterns of genes implicated in UTMs.
• Proposing the use of mouse models for preclinical testing of gene transfer protocols.

Main Results:

• Identified specific genes involved in urinary tract development whose mutations cause UTMs.
• Demonstrated successful gene transfer in mouse models for other congenital diseases.
• Established a rationale for applying gene therapy to congenital urinary tract defects.

Conclusions:

• Genetic and molecular understanding of UTMs supports the development of gene therapies.
• Viral vector-mediated gene transfer holds promise for treating developmental urinary tract defects.
• Preclinical testing in animal models is crucial for advancing gene therapy for UTMs.